RESUMEN
Background: The acute metabolic complications of diabetes consist of diabetic ketoacidosis (DKA), hyperosmolar non-ketotic coma (HNC), lactic acidosis (LA), and hypoglycemia. All of these are associated with significant morbidity and mortality. These can easily be prevented by early recognition and prompt management. Therefore, this study was conducted to assess the clinicopathological spectrum of acute complications of diabetes mellitus type II.Methods: This observational, analytical study was conducted on 100 patients aged more than 18 years admitted in the ICU with acute complication of Diabetes mellitus Type II. Medical history was recorded. Physical examination and investigations were done and recorded.Results: The mean age of the study population was 55.26±13.13 years. Hypoglycemia was more common (63%) than DKA (37%). Fever and sweating had the overall highest incidence (and were more in patients with hypoglycemia) while stupor, nausea and abdominal pain had the lowest incidence (and were more in patients with DKA). On examination, only one patient of DKA was drowsy. Mean temperature, pulse and respiratory rate were higher in the patients having DKA while blood pressure was higher in patients having hypoglycemia.Conclusions: It can be effectively concluded from the present study that DKA and hypoglycaemia have a broad spectrum of clinicopathological features. But the incidences vary widely. This may help in early recognition of the impending complication and thereby enabling prompt management of the same, reducing the associated morbidity and mortality.
RESUMEN
Introduction: The prevalence of diabetes mellitus has been dramatically increasing worldwide, making it an extremely costlychronic disease, both in terms of patient morbidity and health-care expenditure. As many non-communicable diseases havesimilar pathophysiologic mechanisms, so the clinicopathological spectrum and incidences of complications may be expectedto be different from that observed in the general population. However, not many studies are available in this regard. Therefore,this study was conducted to assess the clinicopathological spectrum of the acute complications of diabetes mellitus in relationto hypertension.Materials and Methods: This cross-sectional, analytical study was conducted on patients admitted in the ICU with the acutecomplication of diabetes mellitus. One hundred patients aged more than 18 years were included in the study. Relevant medicalhistory and investigations were recorded.Results: The mean diastolic BP was significantly lower in hypertensive patients. More proportion of hypertensive patients hadderanged creatinine.Conclusion: From the present study, it can be effectively concluded that the epidemiological and clinic-pathological profile ofthe patients having acute complications of diabetes mellitus is significantly different in hypertensive patients than in the nonhypertensives. Further studies need to be done in this regard.
RESUMEN
The microalgal cell wall breakage has been identified as complex phenomenon which is highly dependent onthe nature and composition of cell wall. A detailed analysis of plastids and their function requires the breakingopen of cell without any damage to cellular components. To develop a rapid and universal methodology forcell wall breakage, liquid nitrogen crushing, sonication, enzymatic lysis, and homogenization procedures wereapplied to various microalgal species. Homogenization-based procedure for the isolation of intact chloroplastwas found to be universal for all algal species under the study. The isolated chloroplasts were subjected tochloroplast integrity analysis. The intact chloroplast exhibited a positive maximum quantum yield and Fv/Fm values ranging from 0.1 to 0.4 as measured by pulse amplitude modulation fluorometry and was found tobe suitable for further downstream applications such as isolation of protein–pigment complexes involved inphotosynthetic O2 evolution. The developed methodology is a quick and efficient technique for the isolation ofintact chloroplasts across different genera of microalgae by employing minor changes in the base protocol as aspecies-specific characteristic
RESUMEN
Background: Central 5-HT and 5-HT serotonergic 2A 2Creceptors are mainly involved in the control ofnigrostriatal and mesolimbic dopaminergic neuronalactivity has been well proved and established. 5-HThas facilitatory effect on stimulated dopamine releaseby stimulating central 5-HT receptors and inhibitory 2Aeffect by stimulating 5-HT receptors. Aim and 2CObjectives: To evaluate 5-HT and 5-HT receptor 2A 2Cblocking activity of Mirtazapine (MIR) and the effectof mirtazapine pre-treatment on Ergometrine (ERG)induced behaviours, Fluoxetine (FLU) induced penileerections and Haloperidol (HAL) induced catalepsy inrats. Material and Methods: Each group wassubdivided into different subgroups consisting 6animals in each. Control group received DimethylSulfoxide (DMSO) and other groups received differentdoses of mirtazapine one hour before ERG/FLU/HAL.Values obtained from control group were comparedwith all remaining groups pre-treatment with differentdoses of MIR. Results: MIR (MIR) at 2.5, 5, 10 and 20mg/kg intraperitoneally (i.p) did not produce any per seeffects. Pre-treatment with 5, 10 and 20 mg/kg i.p. MIRsignificantly antagonised ERG induced behaviours. 5mg/kg i.p. MIR significantly antagonised whereas 10and 20 mg/kg i.p. MIR abolished FLU (10 mg/kg)induced penile erections in rats. MIR 5 and 20 mg/kgi.p. significantly antagonised HAL (1mg/kg) inducedcatalepsy at 1 hr testing time interval while 10 and 20mg/kg MIR significantly antagonised HAL (1 mg/kg)induced catalepsy at 2 hr testing time interval.Conclusion: Our results indicate that MIR at 5, 10 and20 mg/kg possesses 5-HT and 5-HT receptors 2A 2Cblocking activity. At 5, 10 and 20 mg/kg MIR, byblocking central 5-HT receptors predominantly, 2Ccauses release of dopamine from nigrostriataldopaminergic neurons and therefore antagonizes HALinduced catalepsy
RESUMEN
Objectives: To study disease severity and response to enzyme replacement therapy in Gaucher disease. Methods: Updated data was captured from records of 37 patients (35 reported previously) with confirmed diagnosis of Gaucher disease from January 1995 through December 2011 (31, 83.8 %) and prospectively from January 2012 through June 2013 (6, 16.2 %). Severity of manifestations was determined by Gaucher disease Severity Score Index. Response to enzyme replacement therapy was assessed in terms of attainment of therapeutic goals. Results: Moderate to severe manifestations (domain score of > 2) were observed in treated patients at baseline (83%, 58%, 66% and 25% for anemia, thrombocytopenia, hepatomegaly and leucopenia, respectively and 100% for splenomegaly and elevated plasma chitotriosidase). None of the 11 patients treated with synthetic enzyme (average annual dose 23 to 53 units/kg) attained all therapeutic goals in the recommended time frame, particularly the visceral, skeletal and growth domains. Conclusions: Early onset of moderate to severe disease in Indian patients mandates early therapy with optimum doses to ensure attainment of all recommended therapeutic goals.